Lactate acidosis is a feature shared by solid hypoxic cancerous tumours, including those that develop in the breast, colon, and prostate. Even though extreme lactate acidosis is damaging to healthy cells, malignant tumours actually benefit from it in a number of different ways. Lactate is utilized by tumour cells as a means of promoting their development, resisting the effects of chemotherapy, and increasing their ability to evade the immune system. Hypoxic cancer cells, which lack oxygen, have the potential to learn the most aggressive behaviors thanks to the benefits of lactic acidosis. Because aggressive hypoxic cancer cells have a high chance of metastasizing to other organs, it is difficult to manage a tumour at this stage with chemotherapy due to the fact that it can be a challenge. Stopping hypoxia-induced lactate dehydrogenase from working can prevent cancers from behaving in an aggressive manner. In this article, we will investigate how hypoxia-induced lactic acidosis leads to the aggressive transformation of malignant cells. This review also offers fresh perspectives on the variety of LDH isoforms as well as the inhibitors that specifically target those isoforms.